Regarding the alternative medications, we found an increasing trend in rates of use for the indications epilepsy and bipolar diseases across the study period in most databases (i.e., DNR [Denmark], ARS [Italy], PHARMO [Netherlands] and CPRD [UK]), while the rates for migraine were mostly steady.
← all excerpts
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
1
—
—